🔎 Trials Near Me

Почетна › Немалоклетни карцином плућа › Havaji

Kliničke studije za Немалоклетни карцином плућа u državi Havaji

12 studija za Немалоклетни карцином плућа traži učesnike na lokacijama u državi Havaji.

Gradovi u državi Havaji

Zvanični tekst studije (na engleskom)

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

  • Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
  • Queen's Cancer Cenrer - POB I, Honolulu
  • Queen's Medical Center, Honolulu
  • и још 4
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06498635

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

  • Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
  • Queen's Cancer Cenrer - POB I, Honolulu
  • Queen's Medical Center, Honolulu
  • и још 5
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04267848

Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)

  • Hawaii Cancer Care - Honolulu, Honolulu
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT04886804

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
  • Queen's Cancer Center - POB I, Honolulu
  • Queen's Medical Center, Honolulu
  • и још 10
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06418204

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

  • Kaiser Permanente Moanalua Medical Center /ID# 238363, Honolulu
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 29. 10. 2026. · NCT04928846

Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

  • The Queens Medical Center, Honolulu
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT06899126

A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

  • Kaiser Permanente Moanalua Medical Center /ID# 272916, Honolulu
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT06568939

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

  • Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
  • Queen's Cancer Cenrer - POB I, Honolulu
  • Queen's Medical Center, Honolulu
  • и још 6
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06116682

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

  • Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
  • Queen's Cancer Cenrer - POB I, Honolulu
  • Queen's Medical Center, Honolulu
  • и још 2
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 6. 2026. · NCT05642572

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

  • Spark M. Matsunaga VA Medical Center, Honolulu
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 30. 4. 2026. · NCT05297734

GEMINI-NSCLC: NSCLC Biomarker Study

  • Hawaii Cancer Care, Honolulu
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 5. 2. 2026. · NCT05236114

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.